GLOSTRUP, Denmark, July 7, 2014 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics , today announced positive findings in a white paper by ProPath Services comparing Dako’s HER2 IQFISH pharmDx(TM) kit with Abbott’s PathVysion HER-2 DNA Probe kit.
ProPath Services is an independent anatomic pathology laboratory headquartered in Dallas, Texas. The white paper, written by Debra S. Cohen, BS, CG(ASCP)CM and Sharon Alsobrook, CG(ASCP)CM, MLS(ASCP)CM, is based on ProPath’s comprehensive, eight-month study of 1,500 formalin-fixed, paraffin-embedded tissue sections.
Help employers find you! Check out all the jobs and post your resume.
